Revelation Biosciences
REVB
8 hedge funds and large institutions have $49.4K invested in Revelation Biosciences in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
100% more funds holding
Funds holding: 4 → 8 (+4)
0.01% less ownership
Funds ownership: 0.01% → 0.01% (-0.01%)
41% less capital invested
Capital invested by funds: $84.3K → $49.4K (-$34.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$34.6K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$20.3K |
| 3 |
SG
StoneX Group
New York
|
+$9.86K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.59K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$133 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$36K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$34.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.3K |
REVB Hedge Fund Activity: Q4 2024 in Review
8 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q4 2024, worth a combined $49.4K — down 41% from $84.3K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new REVB positions and 3 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $34.6K. The largest seller was Sabby Management, exiting entirely with an estimated $36K sold.
- 8 institutional investors held Revelation Biosciences (REVB) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $49.4K of Revelation Biosciences stock for Q4 2024, down 41% quarter-over-quarter.
- 7 funds opened new Revelation Biosciences positions in Q4 2024 and 3 closed out, a net change of +4 holders.
- The largest Revelation Biosciences buyer in Q4 2024 was XTX Topco, an estimated $34.6K added.
- The largest Revelation Biosciences seller in Q4 2024 was Sabby Management, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2024.